Preliminary Scientific Programme
Day 1 | Tuesday, 2 May 2023
| From 7:30 a.m. | Registration Counter open | |
| 09:00 - 09:30 a.m. | Opening remarks | Klaus Pantel, Germany |
| Welcome address of the dean of the University Medical Centre Hamburg | Blanche Schwappach-Pignataro, Germany | |
| Session 1 | Cancer Biology | |
| 09:30 - 10:00 a.m. | Mechanisms of Metastatic Awakening | Robert Weinberg, USA |
| 10:00 - 10:30 a.m. | Circulating Tumor Cell Clusters | Nicola Aceto, Switzerland |
| 10:30 - 11:00 a.m. | Tumor-derived extracellular vesicle DNA: novel configuration and immune regulation in cancer | David Lyden, USA |
| 11:00 - 11:15 a.m. | Short talks selected from proffered abstracts | TBD |
| 11:15 - 11:30 a.m. | Short talks selected from proffered abstracts | TBD |
| 11:30 - 11:45 a.m. | Coffee Break | |
| Session 2 | Cancer Immunology | |
| 11:45 a.m. - 12:30 p.m. | Keynote by Tasuko Honjo, Nobel Laureate 2018, Japan | |
| 12:30 - 01:00 p.m. | Gut microbiota fingerprint predicting resistance to cancer immunotherapy | Laurence Zitvogel, France |
| 01:00 - 01:15 p.m. | Short talks selected from proffered abstracts | TBD |
| 01:15 - 01:30 p.m. | Short talks selected from proffered abstracts | TBD |
| 01:30 - 02:45 p.m. | Lunch Break | |
| Session 3 | Liquid Biopsy-Based Detection of Primary Cancer & Minimal Residual Cancer – Part I | |
| 02:45 - 03:15 p.m. | Clinical applications of MRD | Nickolas Papadopoulos, USA |
| 03:15 - 03:45 p.m. | Liquid Biopsy: From Discovery to Clinical implementation | Klaus Pantel, Germany |
| 03:45 - 04:00 p.m. | Short talks selected from proffered abstracts | TBD |
| 04:00 - 04:15 p.m. | Short talks selected from proffered abstracts | TBD |
| 04:15 - 06:15 p.m. | Poster Session with Coffee | |
Day 2 | Wednesday, 3 May 2023
| Session 4 | Liquid Biopsy and Immuno-Oncology | |
| 09:00 - 09:30 a.m. | Targeting mismatch repair with immunotherapy | Luis Diaz, USA |
| 09:30 - 10:00 a.m. | Catherine Alix-Panabières, France | |
| 10:00 - 10:15 a.m. | Short talks selected from proffered abstracts | TBD |
| 10:15 - 10:30 a.m. | Short talks selected from proffered abstracts | TBD |
| 10:30 - 11:00 a.m. | Coffee Break | |
| Session 5 | Immunotherapy for Prevention of Metastatic Progression – Part I | |
| 11:00 - 11:30 a.m. | Harnessing Natural Killer cells in cancer | Eric Vivier, France |
| 11:30 a.m. - 12:00 p.m. | Claudin6-directed therapy approaches in solid tumors | Carsten Bokemeyer, Germany |
| 12:00 - 12:15 p.m. | Short talks selected from proffered abstracts | TBD |
| 12:15 - 12:30 p.m. | Short talks selected from proffered abstracts | TBD |
| 12:30 - 02:00 p.m. | Lunch Break | |
| Session 6 | Liquid Biopsy-Based Detection of Primary Cancer & Minimal Residual Cancer – Part II | |
| 02:00 - 02:30 p.m. | Pushing the boundaries to expand diagnostic applications of circulating DNA | Nitzan Rosenfeld, UK |
| 02:30 - 03:00 p.m. | Integration of liquid biopsies into molecular tumor boards | Ellen Heitzer, Austria |
| 03:00- 03:30 p.m. | Circulating Tumor DNA for Minimal Residual Disease Detection and Risk-Stratified Recurrence Surveillance in Colorectal Cancer | Claus Lindbjerg Andersen, Denmark |
| 03:30 - 03:45 p.m. | Short talks selected from proffered abstracts | TBD |
| 03:45 - 04:00 p.m. | Short talks selected from proffered abstracts | TBD |
| 04:00 - 04:30 p.m. | Rita Zamarchi Award | |
| 04:30 - 06:30 p.m. | Poster Session with Coffee | |
Day 3 | Thursday, 4 May 2023
| Session 7 | Latest developments in Liquid biopsy-based monitoring of MRD | |
| 09:00 - 09:15 a.m. | TBD | |
| 09:15 - 09:30 a.m. | TBD | |
| 09:30 - 09:45 a.m. | TBD | |
| 09:45 - 10:00 a.m. | TBD | |
| 10:00 - 10:30 a.m. | Coffee Break | |
| Session 8 | Immunotherapy for prevention of metastatic progression – Part II | |
| 10:30 - 11:00 a.m. | Immunotherapy of Lung Cancer – Current Status in metastatic and non-metastatic NSCLC | Martin Reck, Germany |
| 11:00 - 11:30 a.m. | Liquid biopsy & lung cancer immunotherapy: Between hope and hype in routine practice | Paul Hofman, France |
| 11:30 a.m. - 12:00 p.m. | Omics-driven identification of therapeutic resistance in metastatic melanoma patients receiving immune checkpoint inhibition | Christoffer Gebhardt, Germany |
| 12:00 - 12:30 p.m. | Outlook of Clinical Applications of Liquid Biopsy | Howard Scher, USA |
| 12:30 - 01:00 p.m. | Young Investigator Awards | |
| 01:00 - 01:15 p.m. | Concluding Remarks | Klaus Pantel, Germany |